Engineers have designed nanoparticle sensors that can diagnose lung diseases....
Engineers have designed nanoparticle sensors that can diagnose lung diseases. If a disease-associated protein is present in the lungs, the protein cleaves a gaseous molecule from the nanoparticle, and this gas can be detected in the patient’s breath.
Source: Cygny Malvar

'Smart' breathalizer can reveal lung disease

Using specialized nanoparticles, MIT engineers have developed a way to monitor pneumonia or other lung diseases by analyzing the breath exhaled by the patient.

In a study of mice, the researchers showed that they could use this system to monitor bacterial pneumonia, as well as a genetic disorder of the lungs called alpha-1 antitrypsin deficiency. “We envision that this technology would allow you to inhale a sensor and then breathe out a volatile gas in about 10 minutes that reports on the status of your lungs and whether the medicines you are taking are working,” says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science at MIT.

More safety testing would be needed before this approach could be used in humans, but in the mouse study, no signs of toxicity in the lungs were observed.

Monitoring the breath

For several years, Bhatia’s lab has been working on nanoparticle sensors that can be used as “synthetic biomarkers.” These markers are peptides that are not naturally produced by the body but are released from nanoparticles when they encounter proteins called proteases.

The peptides coating the nanoparticles can be customized so that they are cleaved by different proteases that are linked to a variety of diseases. If a peptide is cleaved from the nanoparticle by proteases in the patient’s body, it is later excreted in the urine, where it can be detected with a strip of paper similar to a pregnancy test. Bhatia has developed this type of urine test for pneumonia, ovarian cancer, lung cancer, and other diseases.

More recently, she turned her attention to developing biomarkers that could be detected in the breath rather than the urine. This would allow test results to be obtained more rapidly, and it also avoids the potential difficulty of having to acquire a urine sample from patients who might be dehydrated, Bhatia says.

She and her team realized that by chemically modifying the peptides attached to the synthetic nanoparticles, they could enable the particles to release gases called hydrofluoroamines that could be exhaled in the breath. The researchers attached volatile molecules to the end of the peptides in such a way that when proteases cleave the peptides, they are released into the air as a gas.

Working with Roderick Kunz and Ta-Hsuan Ong at Lincoln Laboratory, Bhatia and her team devised a method for detecting the gas from the breath using mass spectrometry. The researchers then tested the sensors in mouse models of two diseases — bacterial pneumonia caused by Pseudomonas aeruginosa, and alpha-1 antitrypsin deficiency. During both of these diseases, activated immune cells produce a protease called neutrophil elastase, which causes inflammation.

For both of these diseases, the researchers showed that they could detect neutrophil elastase activity within about 10 minutes. In these studies, the researchers used nanoparticles that were injected intratracheally, but they are also working on a version that could be inhaled with a device similar to the inhalers used to treat asthma.

Smart detection

The researchers also demonstrated that they could use their sensors to monitor the effectiveness of drug treatment for both pneumonia and alpha-1 antitrypsin deficiency. Bhatia’s lab is now working on designing new devices for detecting the exhaled sensors that could make them easier to use, potentially even allowing patients to use them at home. “Right now we’re using mass spectrometry as a detector, but in the next generation we’ve been thinking about whether we can make a smart mirror, where you breathe on the mirror, or make something that would work like a car breathalyzer,” Bhatia says.

Her lab is also working on sensors that could detect more than one type of protease at a time. Such sensors could be designed to reveal the presence of proteases associated with specific pathogens, including perhaps the SARS-CoV-2 virus.

The paper was published in Nature Nanotechnology.

Subscribe to our newsletter

Related articles

Can ‘smart toilets’ be the next

Can ‘smart toilets’ be the next

Wearables are transforming the ability to monitor and improve health, but a decidedly low-tech commodity—the humble toilet—may have potential to outperform them all.

Self-aware materials for living structures

Self-aware materials for living structures

Researchers at University of Pittsburgh have developed a revolutionary scalable material that senses and powers itself.

“Smart Hospital Beds” to prevent falls

“Smart Hospital Beds” to prevent falls

5G smart beds, a prototype innovation to prevent elderly patients from falls in both hospitals and homes was showcased recently.

Sensor warns of impending COVID-19 cytokine storm

Sensor warns of impending COVID-19 cytokine storm

Scientists report preliminary results on a sweat sensor that acts as an early warning system for an impending cytokine storm, which could help doctors more effectively treat patients.

Tattoo made of gold nanoparticles for diagnostics

Tattoo made of gold nanoparticles for diagnostics

Scientists have developed a novel type of implantable sensor which can be operated in the body for several months to transmit information on vital values and concentrations of substances or drugs in the body.

Sticker detects cystic fibrosis in newborn's sweat

Sticker detects cystic fibrosis in newborn's sweat

Researchers have developed a novel skin-mounted sticker that absorbs sweat and then changes color to provide an accurate, easy-to-read diagnosis of cystic fibrosis within minutes.

Aged care monitoring and alert technology

Aged care monitoring and alert technology

Sleeptite has launched the world-first smart monitoring system, REMi, delivering real-time and non-invasive resident monitoring and alerts.

Microfluidic chip simplifies COVID-19 testing

Microfluidic chip simplifies COVID-19 testing

COVID-19 can be diagnosed in 55 minutes or less with the help of programmed magnetic nanobeads and a diagnostic tool that plugs into an off-the-shelf cellphone.

Biodegradable displays for sustainable sensors

Biodegradable displays for sustainable sensors

Scientists have developed biodegradable displays that due to their flexibility and adhesion can be worn directly on the hand.

Popular articles

Subscribe to Newsletter